Scancell Holdings Plc (LON:SCLP) shares crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $7.03 and traded as high as $6.29. Scancell shares last traded at $6.07, with a volume of 429,631 shares trading hands.

The firm has a 50 day moving average of GBX 7 and a 200-day moving average of GBX 6.47. The company has a market cap of $28.39 million and a P/E ratio of -4.07.

About Scancell (LON:SCLP)

Scancell Holdings plc engages in the discovery and development of novel monoclonal antibodies and vaccines for the treatment of cancer in the United Kingdom. The company's products include SCIB1, a plasmid DNA vaccine, which is in Phase I/II clinical trials for the treatment of melanoma; SCIB2 to treat lung cancer antigen; and Modi-1, which is in the pre-clinical development to treat triple negative breast cancer, ovarian cancer, and sarcoma.

Read More: What are the reasons investors use put options?

Receive News & Ratings for Scancell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scancell and related companies with MarketBeat.com's FREE daily email newsletter.